//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
12,115.15-10.75
Stock Analysis, IPO, Mutual Funds, Bonds & More

Laurus Labs Ltd.

ET 500

Rank 2019
477
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    14:24 | 20-02-2020
  • BSE
    14:34 | 20-02-2020
441.85

Today's Change

2.10 (0.48%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

59,531

Open

435.20

Prev. Close

438.60

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)10.00
  • EPS-TTM (Rs.)17.61
  • BV/share (₹)146.42
  • 52Wk L/H303.30/ 459.95
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed
Laurus Labs Ltd.Announcement under Regulation 30 (LODR)-Earnings Call Transcript| Announcement
Laurus Labs Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
Laurus Labs Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Laurus Labs Ltd.Unaudited Financial Results For Q3 2019-20| Announcement
Laurus Labs Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Laurus Labs Ltd.Laurus Labs Receives EIR From USFDA For Its FDF & API Integrated Facility, Unit 2, Visakhapatnam| Announcement
Laurus Labs Ltd.Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Period Ended December 31, 2019| Announcement
Laurus Labs Ltd.Shareholding for the Period Ended December 31, 2019| Announcement
Laurus Labs Ltd.Statement Of Investor Complaints For The Quarter Ended December 2019| Announcement
Laurus Labs Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
Laurus Labs Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Laurus Labs Ltd.Closure of Trading Window| Announcement
Laurus Labs Ltd.Request Letter For Reclassification From Promoter Category To Public Category - Dr. Srihari Raju| Announcement
Laurus Labs Ltd.Request Letter For Reclassification From Promoter Category To Public Category - Dr. Srihari Raju| Announcement
Laurus Labs Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Laurus Labs Ltd.Grant Of Stock Options To The Eligible Employees| Announcement
Laurus Labs Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Laurus Labs Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Laurus Labs Ltd.Disclosure Under Regulation 23(9) Of SEBI (LODR)| Announcement
Laurus Labs Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement

Laurus Labs Ltd. Share Price Updates

Laurus Labs Ltd. share price up by 0.48% from its previous close of Rs 438.60. Laurus Labs Ltd. stock last traded price is 441.85
Laurus Labs Ltd. Share Price
Value
Today/Current/Last
441.85
Previous Day
438.60
What's your view on Laurus Labs for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Laurus Labs Ltd.

Laurus Labs Ltd.
Quarterly Results

Figures in Rs. Cr
Dec 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
729.59
2.41
37.80
0.00
8154.85
Other Operating Income
0.00
0.00
0.00
0.00
136.45
Operating Profit
148.17
7.52
68.92
-27.67
2683.77
Other Income
1.92
41.37
35.97
-0.05
119.88
EBITDA
150.09
7.85
68.40
-27.67
2683.77
Interest
20.83
-18.51
-11.93
-0.10
111.00
Depreciation
47.55
-0.59
11.34
0.00
546.99
Tax
8.24
-10.65
66.37
-9.24
767.02
Net Profit
73.47
29.92
312.39
-835.00
1019.38
EPS (₹)
6.88
29.32
311.98
-94.30
31.95

Laurus Labs Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
442.05
0.79
0.17
9.66
30.46
34.59
-12.52
0.00
53.70
4.99
27.40
-82.19
-82.38
-75.72
-69.47
-76.95
361.20
-1.78
3.24
27.12
30.99
-8.01
-49.48
-75.33
166.80
1.49
-0.77
-13.71
5.17
3.70
-47.82
-56.27
514.40
1.81
-3.34
32.07
28.58
25.63
-56.91
-43.95
94.30
-1.00
-2.28
12.00
42.02
46.31
-31.39
0.00
93.00
-0.96
-7.28
16.18
-22.76
-50.16
0.00
0.00
250.45
4.73
-0.14
8.87
24.85
63.43
17.28
62.52
351.40
-0.14
4.16
18.92
2.40
6.05
-13.64
116.66
185.10
-1.52
8.95
25.75
43.32
103.63
47.78
133.27
538.75
0.71
-7.75
11.72
38.62
67.34
61.74
180.89
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Laurus Labs Ltd Risk Return Comparison

with peersNew

Laurus Labs Ltd
Financial Comparison

with peers
Management Efficiency
Laurus Labs Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
6.01
8.93
-99.01
47.57
Return on Assets (%)
2.82
5.57
-27.48
26.25
Return on capital Employed (%)
6.29
5.95
-130.86
23.02
Fixed Assets Turnover (x)
0.94
-1.87
-193.68
2.79
Profitability and Growth
Gross Profit Margin (%)
8.36
-8.25
-980.00
34.42
Operating Profit Margin(%)
15.53
0.75
-896.19
37.94
Net Profit margin (%)
4.09
1.91
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.03
1.62
0.08
9.50
Current Ratio (x)
1.91
2.36
0.21
9.50
Cash ratio (x)
0.00
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.17
0.29
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
3.66
3.92
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Laurus Labs Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
Promoters34,835,94032.58
FinancialInstitutions29,055,26227.18
GeneralPublic17,163,52116.05
ForeignInstitutions11,242,97410.52
Others9,354,6678.75
NBanksMutualFunds5,262,1354.92

MF Ownership Of Laurus Labs Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
Equity: Sectoral-Pharma
1331031
-11.54%
4.52%
57.28
Kotak Emerging Equity Direct-G
Portfolio as on 31-01-2020
Equity: Mid Cap
980180
0.00%
0.63%
42.18
Kotak Small Cap Direct-G
Portfolio as on 31-01-2020
Equity: Small Cap
449801
0.00%
1.22%
19.36
Sundaram Small Cap Direct-G
Portfolio as on 31-01-2020
Equity: Small Cap
394704
0.00%
1.48%
16.99
Mirae Asset Healthcare Fund Direct-G
Portfolio as on 31-01-2020
Equity: Sectoral-Pharma
260589
0.00%
2.85%
11.21

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Laurus Labs Ltd.

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 4690.87 Crore) operating in Pharmaceuticals sector.

Laurus Labs Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 2074.07 Crore to Sales Value (92.75 % of Total Sales), Contract Service which contributed Rs 84.48 Crore to Sales Value (3.77 % of Total Sales), Export Incentives which contributed Rs 26.54 Crore to Sales Value (1.18 % of Total Sales), Traded Goods which contributed Rs 26.39 Crore to Sales Value (1.18 % of Total Sales), Other Operating Revenue which contributed Rs 22.46 Crore to Sales Value (1.00 % of Total Sales) and Scrap which contributed Rs 2.21 Crore to Sales Value (0.09 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 729.59 Crore, up 2.41 % from last quarter Sales of Rs 712.42 Crore and up 37.80 % from last year same quarter Sales of Rs 529.46 Crore Company has reported net profit after tax of Rs 73.48 Crore in latest quarter.

The company’s top management includes Dr.M Venu Gopala Roa, Mr.Venkata Ravi Kumar Vantaram, Mr.Ramesh Subrahmanian, Mr.Narendra Ostawal, Mr.Chandrakanth Chereddi, Dr.Venkata Lakshmana Rao Chunduru, Dr.Satyanarayana Chava, Dr.Ravindranath Kancherla, Dr.Rajesh Koshy Chandy, Ms.Aruna Rajendra Bhinge. Company has Deloitte Haskins & Sells LLP as its auditors As on 31-12-2019, the company has a total of 106,914,499 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors